BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pharmion Corporation 

2525 28th Street, Suite 200

Boulder  Colorado  80301  U.S.A.
Phone: 720-564-9100 Fax: 720-564-9191


SEARCH JOBS


Industry
Pharmaceutical






 Company News
FDA Requests Label Change for Pharmion Corporation (PHRM)'s Tinzaparin 12/3/2008 7:35:27 AM    More...
Celgene (CELG) Subsidiary Pharmion Corporation (PHRM) Withdraws European Marketing Application for Orplatna 8/14/2008 6:37:08 AM    More...
Celgene Corporation (CELG) Completes $2.9 Billion Acquisition of Pharmion Corporation (PHRM) 3/10/2008 9:08:32 AM    More...
Celgene Corporation (CELG) and Pharmion Corporation (PHRM) Announce Shareholder Vote in Favor of Acquisition of Pharmion Corporation (PHRM) 3/6/2008 9:13:53 AM    More...
ISS Recommends Pharmion Corporation (PHRM) Shareholders Vote for Merger With Celgene (CELG) 2/27/2008 8:36:20 AM    More...
Pharmion Corporation (PHRM) Announces 2007 Operating Results 2/19/2008 10:35:09 AM    More...
Pharmion Corporation (PHRM) and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/14/2008 8:01:55 AM    More...
MethylGene and Pharmion Corporation (PHRM) Announce Orphan Drug Designation Granted by the European Medicines Evaluation Agency for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/11/2008 10:00:41 AM    More...
Pharmion Corporation (PHRM) and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/11/2008 8:18:10 AM    More...
Pharmion Corporation (PHRM) Release: EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 2/7/2008 8:27:35 AM    More...
12345678910...

//-->